Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GrayBug logo — Saving Sight Through Transformative Science.

GrayBug

Saving Sight Through Transformative Science.

Founded 2011 United States Redwood City, United States 4 employees Series C Total: $129.24M Biotechnology, Health Care +1

General Information

Company Name GrayBug
Founded Year 2011
Location United States Redwood City, United States +2
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

Get notified when GrayBug moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GrayBug

GrayBug, founded in 2011, is a biopharmaceutical company committed to developing transformative medicines for ocular diseases. With the slogan, "Saving Sight Through Transformative Science.", they are leveraging technology licensed from the Johns Hopkins University School of Medicine.

Based in Redwood City, California and Baltimore, Maryland, GrayBug operates in the Biotechnology, Health Care, and Pharmaceutical sectors, positioning itself at the intersection of innovation and healthcare solutions.

The company secured an impressive $80.00M Series C investment on 20 August 2019, signaling strong confidence from notable investors including Hatteras Venture Partners, OrbiMed, C-Bridge Capital, and Deerfield Capital Management. This financial backing highlights the significant interest and potential perceived in GrayBug's mission and its innovative contributions to the field of eye health.

Taxonomy: Biopharmaceutical, Ocular Diseases, Transformative Medicines, Johns Hopkins University Technology, Calcium Release-Activated Calcium Channels, Immune Response Modulation, Tissue Cell Protection, Inflammatory Diseases, Proprietary Technology, Therapeutic Development, Vision Health, Pharmaceutical R&D, Licensing and Partnerships, Ophthalmology

Services & Products

Slot Games
Live Casino
Sports Betting
Lottery Services
Instant Deposit and Withdrawal

Target Customers

Online Gamblers Casino Enthusiasts Sports Bettors Esports Fans Individuals seeking Lottery Games

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor Investor Investor
20 Aug 2019
Series B •••••• 4
Investor Investor
•••• •••• 		02 May 2016
Debt Financing •••••• - 16 Dec 2015
Series A •••••• 2
Investor Investor
06 Mar 2015
Venture Round •••••• - 07 Oct 2014

View All 6 Funding Rounds

GrayBug Alternatives & Competitors

View All Alternatives
GrayBug vs
ChemiCare | It's a rare thing to care
ChemiCare | It's a rare thing to care Italy

Cutting-edge drugs for calcium-related diseases

Grant
4 employees
Health Care, Pharmaceutical
GrayBug vs
Epitope Diagnostics, Inc.
Epitope Diagnostics, Inc. United States

Epitope Diagnostics, Inc. is an ISO 13845 certified medical device manufacture company located in th...

14 employees
Biotechnology, Health Care
GrayBug vs
AmyPore
AmyPore France

New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and othe...

Non Equity Assistance
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About GrayBug

Saving Sight Through Transformative Science.
GrayBug was founded in 2011.
GrayBug is headquartered in Redwood City, United States.
GrayBug operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
GrayBug has approximately 4 employees.
GrayBug has completed 6 funding rounds, raising a total of $129.24M. The latest funding stage is Series C.
GrayBug offers: Slot Games, Live Casino, Sports Betting, Lottery Services, Instant Deposit and Withdrawal.
Top alternatives and competitors to GrayBug include ChemiCare | It's a rare thing to care, Epitope Diagnostics, Inc., AmyPore, KALSIOM SAS, Calcium Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GrayBug and ChemiCare | It's a rare thing to care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GrayBug and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy